Frazier Management’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-899,700
Closed -$31.3M 4
2021
Q4
$31.3M Hold
899,700
2.41% 16
2021
Q3
$24.4M Hold
899,700
1.95% 15
2021
Q2
$23.3M Hold
899,700
2.15% 11
2021
Q1
$19.4M Hold
899,700
1.56% 14
2020
Q4
$19.3M Sell
899,700
-1,416,747
-61% -$34.4M 1.49% 14
2020
Q3
$34.2M Hold
2,316,447
3.07% 9
2020
Q2
$51.7M Hold
2,316,447
4.54% 6
2020
Q1
$32.7M Hold
2,316,447
3.71% 7
2019
Q4
$37.6M Hold
2,316,447
6.31% 6
2019
Q3
$81.1M Hold
2,316,447
25.34% 1
2019
Q2
$131M Hold
2,316,447
33.49% 1
2019
Q1
$169M Hold
2,316,447
40.73% 1
2018
Q4
$148M Hold
2,316,447
38.13% 1
2018
Q3
$231M Hold
2,316,447
42.32% 1
2018
Q2
$165M Sell
2,316,447
-1,372,001
-37% -$115M 34.09% 1
2018
Q1
$384M Hold
3,688,448
63.7% 1
2017
Q4
$372M Hold
3,688,448
60.25% 1
2017
Q3
$129M Hold
3,688,448
45.97% 1
2017
Q2
$88.3M Hold
3,688,448
45.24% 1
2017
Q1
$102M Buy
+3,688,448
New +$85.9M 54.68% 1

Other funds holding ANAB

Frazier Management's ANAB Position: Q1 2022 in Review

Frazier Management sold out of AnaptysBio (ANAB) in Q1 2022, closing a stake of 899,700 shares — an estimated $31.3M sold.

Frazier Management first reported a position in ANAB in Q1 2017 and held it in 20 quarters. The position peaked at $384M in Q1 2018. 131 funds tracked by Wall St. Rank hold ANAB as of Q1 2022.

  • Frazier Management reported no remaining AnaptysBio position as of Q1 2022 after selling out during the quarter.
  • Frazier Management sold 899,700 AnaptysBio shares in Q1 2022, an estimated $31.3M.
  • Frazier Management first reported a position in AnaptysBio in Q1 2017 and held it in 20 quarters.
  • Frazier Management's AnaptysBio position peaked at $384M in Q1 2018.
  • 131 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2022.

Based on Frazier Management's 13F filing for Q1 2022, filed 13 May 2022.